Redmile Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,219,616
Closed -$66.3M 76
2017
Q2
$66.3M Buy
+2,219,616
New +$66.3M 4.04% 6